Author:
Tripathy Ratikanta,Das Swarnalata,Das Palash,Mohakud Nirmal K,Das Mangalacharan
Reference21 articles.
1. World Health Organization (WHO). Importance of pharmacovigilance --- safety monitoring of medicinal products. Uppsala. The Uppsala Monitoring Centre; 2002. (2002). Accessed: June 16, 2021: http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf.
2. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study;Lima ED;J Pediatr (Rio J),2019
3. Children and ADRs (adverse drug reactions);Napoleone E;Ital J Pediatr,2010
4. Pharmacovigilance in India: present scenario and future challenges;Kalaiselvan V;Drug Saf,2019
5. Reporting of adverse drug reactions in India: a review of the current scenario, obstacles and possible solutions;Mulchandani R;Int J Risk Saf Med,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献